back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-04 11:49 Tx date 2026-02-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-65,384 vol |
141,859 | |
| Filed 2026-03-04 11:39 Tx date 2026-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+38,963 vol |
347,831 | |
| Filed 2026-03-04 11:37 Tx date 2026-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-76,474 vol |
65,385 | |
| Filed 2026-03-04 11:32 Tx date 2026-02-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
56 - Grant of rights
|
+57,229 vol |
163,205 | |
| Filed 2026-03-04 11:31 Tx date 2026-02-27 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,336,929
+95,700 vol $13.97 each |
668,766 | |
| Filed 2026-02-23 15:08 Tx date 2026-02-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
+65,384 vol |
||
| Filed 2026-02-23 15:10 Tx date 2026-02-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+32,960 vol |
308,868 | |
| Filed 2026-02-23 15:08 Tx date 2026-02-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
+65,384 vol |
272,627 | |
| Filed 2026-01-06 12:45 Tx date 2026-01-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+2,889 vol |
275,908 | |
| Filed 2026-01-06 12:45 Tx date 2026-01-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+12,492 vol |
273,019 | |
| Filed 2026-01-06 12:44 Tx date 2026-01-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+29,223 vol |
260,527 | |
| Filed 2026-01-06 12:42 Tx date 2026-01-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
57 - Exercise of rights
|
$-391,078.05
-24,519 vol $15.95 each |
105,976 | |
| Filed 2026-01-06 12:41 Tx date 2026-01-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
57 - Exercise of rights
|
$-914,844.15
-57,357 vol $15.95 each |
130,495 | |
| Filed 2026-01-06 12:39 Tx date 2026-01-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Award
56 - Grant of rights
|
+49,038 vol |
187,852 | |
| Filed 2025-03-11 14:10 Tx date 2023-12-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-50,000 vol |
448,673 | |
| Filed 2025-03-11 14:09 Tx date 2023-12-31 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-132,440 vol |
498,673 | |
| Filed 2025-03-05 11:07 Tx date 2025-02-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$939,167
+124,393 vol $7.55 each |
755,506 | |
| Filed 2025-03-05 11:00 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-605,674.08
-76,474 vol $7.92 each |
207,243 | |
| Filed 2025-03-05 10:56 Tx date 2025-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-274,776.48
-34,694 vol $7.92 each |
283,717 | |
| Filed 2025-03-05 10:54 Tx date 2025-03-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
$-523,072
-65,384 vol $8.00 each |
318,411 |